Avalyn Pharma Funding & Investors
Avalyn Pharma Inc. operates as a pharmaceutical company. The Company develops treatments for Idiopathic Pulmonary Fibrosis (IPF).
avalynpharma.comTotal Amount Raised: $272,500,000
Avalyn Pharma Funding Rounds
Series C
$175,000,000
Series C Investors
EventidePerceptive AdvisorsSr OneWellington ManagementCatalio Capital ManagementPiper Heartland Healthcare CapitalVida VenturesPivotal bioVenture Partners Investment AdvisorSurveyor CapitalRock Springs CapitalRiverVestNorwest Venture PartnersF-Prime CapitalNovo HoldingsSeries B
$35,500,000
Series B Investors
Norwest Venture PartnersF-Prime CapitalPivotal bioVenture Partners Investment AdvisorTPG BiotechRiverVestNovo HoldingsSeries C
$175,000,000
Series C Investors
EventidePerceptive AdvisorsSr OneWellington ManagementCatalio Capital ManagementPiper Heartland Healthcare CapitalVida VenturesPivotal bioVenture Partners Investment AdvisorSurveyor CapitalRock Springs CapitalRiverVestNorwest Venture PartnersF-Prime CapitalNovo HoldingsSeries B
$35,500,000
Series B Investors
Norwest Venture PartnersF-Prime CapitalPivotal bioVenture Partners Investment AdvisorTPG BiotechRiverVestNovo HoldingsSeries A
$62,000,000
Series A Investors
Eight Roads VenturesAndera PartnersRiverVestTPG BiotechF-Prime CapitalNovo HoldingsEdmond de Rothschild Private EquitySeries A
$62,000,000
Series A Investors
Eight Roads VenturesAndera PartnersRiverVestTPG BiotechF-Prime CapitalNovo HoldingsEdmond de Rothschild Private Equity
Funding info provided by Diffbot.